Trial Profile
Clinical Trials to Compare the Pharmacokinetic Profiles of Sarpogrelate hydrochloride 300mg SR Tablet and ANPLAG IR After Oral Administration to Healthy Male Subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Sarpogrelate (Primary)
- Indications Arterial occlusive disorders
- Focus Pharmacokinetics
- Sponsors KunWha Pharmaceutical
- 08 Sep 2016 New trial record